By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Myovant 



Hamilton  Bermuda    United Kingdom
Phone: n/a Fax: n/a


SEARCH JOBS

Myovant Sciences is focused on innovative treatments for women's health conditions and prostate cancer. The company's lead program is relugolix, a phase 3 drug candidate for multiple indications, including uterine fibroids, endometriosis and prostate cancer. Myovant was formed through a strategic partnership between Roivant Sciences and Takeda.

YEAR FOUNDED:

2016

LEADERSHIP:

CEO: Lynn Seely

CFO: Frank Karbe

JOBS:

Please click here for Myovant Sciences job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Private

Web Site: Myovant
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->